16 July 2021 : Original article
Risk Factors Influencing the Outcomes of Kidney Re-Transplantation
Anke Schwarz1ADEF*, Frank Schäfer1AB, Theodor Framke2CD, Silvia Linnenweber-Held1AB, Nicolas Richter3BD, Hermann Haller1DEDOI: 10.12659/AOT.928922
Ann Transplant 2021; 26:e928922
Table 2 Outcome of patient group TX2 (re-transplantation) compared to TX1 (first transplantation) serving as control.
Tx1 N (%) | Tx2 N (%) | p-value | |
---|---|---|---|
Graft failure by rejection | 14 (21.21) | 29 (32.22) | 0.0137 |
Acute rejection | 2 | 10 | |
Chronic rejection | 12 | 19 | |
Graft failure by infection | 3 (4.55) | 5 (5.56) | 0.4795 |
Sepsis | 0 | 2 | |
Pyelonephritis | 1 | 1 | |
BK-Viral nephropathy | 2 | 2 | |
Graft failure by various reasons | 19 (28.79) | 13 (14.44) | 0.2733 |
Recurrence or de novo HUS | 1 | 1 | |
Recurrence or de novo GN | 4 | 1 | |
Recurrence of diabetes | 1 | 0 | |
Early vascular damage | 4 | 0 | |
After PTCA | 1 | 0 | |
After PTA | 1 | 0 | |
After perforating diverticulitis | 1 | 0 | |
Relapsing UT obturation | 0 | 1 | |
Cardiac insufficiency | 1 | 1 | |
Donor-derived renal damage | 0 | 3 | |
Not clarified | 5 | 6 | |
Death with functioning graft | 30 (45.45) | 43 (47.78) | 0.0796 |
Death by infection | 10 | 21 | 0.0411 |
Death by cardiovascular disease | 9 | 9 | |
Death by malignoma | 9 | 9 | |
Death by suicide | 0 | 2 | |
Cause of death not clarified | 2 | 2 | |
HUS– haemolytic uremic syndrome; GN – glomerulonephritis; PTCA – percutaneous transluminal coronary angioplasty; PTA – percutaneous transluminal angioplasty; UT – urinary tract. |